KALA BIO, Inc. (KALA) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 5 Buy, 3 Hold, 1 Sell.
The consensus price target is $18.25 (low: $1.50, high: $35.00), representing an upside of 9420.1% from the current price $0.19.
Analysts estimate Earnings Per Share (EPS) of $-10.84 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.01 vs est $-10.84 (beat +90.7%). Analyst accuracy: 0%.
KALA Stock — 12-Month Price Forecast
$18.25
▲ +9,420.08% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for KALA BIO, Inc., the average price target is $18.25, with a high forecast of $35.00, and a low forecast of $1.50.
The average price target represents a +9,420.08% change from the last price of $0.19.
Highest Price Target
$35.00
Average Price Target
$18.25
Lowest Price Target
$1.50
KALA Analyst Ratings
Buy
Based on 9 analysts giving stock ratings to KALA BIO, Inc. in the past 3 months
EPS Estimates — KALA
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$1.01
vs Est –$10.84
▲ 972.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — KALA
Revenue Trend
Analysts expect stable revenue going forward.
